Epidermal filaggrin deficiency mediates increased systemic T-helper 17 immune response

British Journal of Dermatology

Volumn 175, Issue 4, 2016, Pages 706-712

  Bonefeld, C M ^a   Petersen, T H ^a   Bandier, J ^b   Agerbeck, C ^a   Linneberg, A ^a,c,d   Ross Hansen, K ^b   Stender, S ^b   Szecsi, P B ^b   Johansen, J D ^b   Geisler, C ^a   Thyssen, J P ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Research for Prevention and Health   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; CD4 ANTIGEN; FILAGGRIN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR V BETA CHAIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL COUNT; CELL FRACTIONATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMAL FILAGGRIN DEFICIENCY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; SPLENIC TISSUE; TH1 CELL; TH17 CELL; TH2 CELL; TH22 CELL;

EID: 84990197993     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14570     Document Type: Article

References (33)

1. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358:1483–94.
2. Thyssen JP, Kezic S. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 2014; 134:792–9.
3. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365:1315–27.
4. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441–6.
5. Fallon PG, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009; 41:602–8.
6. Oyoshi MK, Murphy GF, Geha RS. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009; 124:485–93, 493.e1.
7. Kezic S, O'Regan GM, Lutter R et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol 2012; 129:1031–9.e1.
8. Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 2014; 14:585–600.
9. Leisten S, Oyoshi MK, Galand C et al. Development of skin lesions in filaggrin-deficient mice is dependent on adaptive immunity. J Allergy Clin Immunol 2013; 131:1247–50, 1250.e1.
10. Czarnowicki T, Gonzalez J, Shemer A et al. Severe atopic dermatitis is characterized by selective expansion of circulating T2/T2 and T22/T22, but not T17/T17, cells within the skin-homing T-cell population. J Allergy Clin Immunol 2015; 136:104–15.e7.
11. Koga C, Kabashima K, Shiraishi N et al. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128:2625–30.
12. Kabashima-Kubo R, Nakamura M, Sakabe J et al. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type. J Dermatol Sci 2012; 67:37–43.
13. Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011; 11:505–18.
14. Islander U, Andersson A, Lindberg E et al. Superantigenic Staphylococcus aureus stimulates production of interleukin-17 from memory but not naive T cells. Infect Immun 2010; 78:381–6.
15. van Drongelen V, Haisma EM, Out-Luiting JJ et al. Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models. Clin Exp Allergy 2014; 44:1515–24.
16. Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 2010; 126:1184–90.
17. Brauweiler AM, Bin L, Kim BE et al. Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal alpha-toxin-induced keratinocyte death. J Allergy Clin Immunol 2013; 131:421–7.e1–2.
18. Hoff S, Oyoshi MK, Macpherson A, Geha RS. The microbiota is important for IL-17A expression and neutrophil infiltration in lesional skin of Flg(ft/ft) mice. Clin Immunol 2015; 156:128–30.
19. Bandier J, Carlsen BC, Rasmussen MA et al. Skin reaction and regeneration after single sodium lauryl sulfate exposure stratified by filaggrin genotype and atopic dermatitis phenotype. Br J Dermatol 2015; 172:1519–29.
20. Meldgaard M, Szecsi PB, Carlsen BC et al. A novel multiplex analysis of filaggrin polymorphisms: a universally applicable method for genotyping. Clin Chim Acta 2012; 413:1488–92.
21. Williams HC, Burney PG, Hay RJ et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131:383–96.
22. Dyring-Andersen B, Skov L, Lovendorf MB et al. CD4(+) T cells producing interleukin (IL)-17, IL-22 and interferon-gamma are major effector T cells in nickel allergy. Contact Dermatitis 2013; 68:339–47.
23. Nielsen MM, Lovato P, MacLeod AS et al. IL-1beta-dependent activation of dendritic epidermal T cells in contact hypersensitivity. J Immunol 2014; 192:2975–83.
24. Rössle SC, Bisch PM, Lone YC et al. Mutational analysis and molecular modeling of the binding of Staphylococcus aureus enterotoxin C2 to a murine T cell receptor Vbeta10 chain. Eur J Immunol 2002; 32:2172–8.
25. Lane PW. Two new mutations in linkage group XVI of the house mouse. Flaky tail and varitint-waddler-J. J Hered 1972; 63:135–40.
26. Sasaki T, Shiohama A, Kubo A et al. A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis. J Allergy Clin Immunol 2013; 132:1111–20.e4.
27. Saunders SP, Goh CS, Brown SJ et al. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. J Allergy Clin Immunol 2013; 132:1121–9.
28. Sumarac-Dumanovic M, Stevanovic D, Ljubic A et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes 2009; 33:151–6.
29. Winer S, Paltser G, Chan Y et al. Obesity predisposes to Th17 bias. Eur J Immunol 2009; 39:2629–35.
30. Ahmed M, Gaffen SL. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev 2010; 21:449–53.
31. Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol 2015; 135:721–8.e6.
32. Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol 2015; 72:606–16.e4.
33. Wilkinson DS, Fregert S, Magnusson B et al. Terminology of contact dermatitis. Acta Derm Venereol 1970; 50:287–92.